Previous studies have shown that factors like retinoic acid and histone deacetylase inhibitors can induce or stabilize Foxp3 expression, promoting iTreg differentiation in vivo and treating autoimmune diseases (Xiao et al, 2008; Wang et al, 2009, 2015). The gene discussed is FOXP3; the disease is autoimmune disease.